Effects of erdosteine on bleomycin-induced lung fibrosis in rats

被引:0
作者
Haşim Boyacı
Hale Maral
Gupse Turan
İlknur Başyiğit
Meltem Ö. Dillioğlugil
Füsun Yıldız
Melih Tugay
Ayşe Pala
Cengiz Erçin
机构
[1] Kocaeli University School of Medicine,Department of Chest Diseases
[2] Kocaeli University School of Medicine,Department of Biochemistry
[3] Kocaeli University School of Medicine,Department of Pathology
[4] Kocaeli University School of Medicine,Department of Pediatric Surgery
[5] Kocaeli TIP Fakültesi,undefined
来源
Molecular and Cellular Biochemistry | 2006年 / 281卷
关键词
bleomycin; erdosteine; lung; nitric oxide;
D O I
暂无
中图分类号
学科分类号
摘要
This study was designed to examine the effects of erdosteine on bleomycin (BLM)-induced lung fibrosis in rats. Thirty-three Sprague–Dawley rats were divided randomly into three groups, bleomycin alone (BLM), bleomycin + erdosteine (BLM + ERD), and saline alone (control). The BLM and BLM + ERD groups, were given 2.5 mg/kg BLM intratracheally. The first dose of oral erdosteine (10 mg/kg/day) in the BLM + ERD group was started 2 days before BLM administration and continued until animals were sacrificed. Animals were sacrificed 14 days after intratracheal instillation of BLM. The effect of erdosteine on pulmonary fibrosis was studied by analysis of bronchoalveolar lavage (BAL) fluid, histopathology, and biochemical measurements of lung tissue superoxide dismutase (SOD) and glutathione (GSH) as antioxidants, malondialdehyde (MDA) as an index for lipid peroxidation, and nitrite/nitrate levels. Bleomycin-induced lung fibrosis as determined by lung histology was prevented with erdosteine (grades of fibrosis were 4.9, 2.3, and 0.2 in BLM, BLM + ERD, and control groups, respectively). Erdosteine also prevented bleomycin-induced increase in MDA (MDA levels were 0.50 ± 0.15, 0.11 ± 0.02, and 0.087± 0.03 nmol/mg protein in BLM, BLM + ERD, and control groups, respectively) and nitrite/nitrate (nitrite/nitrate levels were 0.92 ± 0.06, 0.60 ± 0.09, and 0.56± 0.1 μmol/mg protein in BLM, BLM + ERD, and control groups respectively) levels. Bleomycin-induced decrease in GSH and SOD levels in the lung tissue also prevented by erdosteine [(GSH levels were 213.5 ± 12.4, 253.2± 25.2, and 287.9± 34.4 nmol/mg protein) (SOD levels were 1.42± 0.12, 1.75± 0.17, and 1.89± 0.09 U/mg protein) in BLM, BLM + ERD, and control groups respectively]. Erdosteine prevented bleomycin-induced increases in total cell number and neutrophil content of the BAL fluid. In conclusion, oral erdosteine is effective in prevention of BLM-induced lung fibrosis in rats possibly via the repression of neutrophil accumulation, inhibition of lipid peroxidation, and maintenance of antioxidant and free radical scavenger properties.
引用
收藏
页码:129 / 137
页数:8
相关论文
共 50 条
  • [21] Effect of Resveratrol on Treatment of Bleomycin-Induced Pulmonary Fibrosis in Rats
    Akgedik, Recep
    Akgedik, Sukran
    Karamanli, Harun
    Uysal, Sema
    Bozkurt, Bulent
    Ozol, Duygu
    Armutcu, Ferah
    Yildirim, Zeki
    [J]. INFLAMMATION, 2012, 35 (05) : 1732 - 1741
  • [22] Efficacies of rosiglitazone and retinoin on bleomycin-induced pulmonary fibrosis in rats
    Yu, Wencheng
    Mi, Liyun
    Long, Teng
    [J]. EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2017, 14 (01) : 609 - 615
  • [23] The Integrin Inhibitor Cilengitide and Bleomycin-Induced Pulmonary Fibrosis Cilengitide and Bleomycin-Induced Pulmonary Fibrosis
    Ritzenthaler, Jeffrey D.
    Zhang, Michael
    Torres-Gonzalez, Edilson
    Roman, Jesse
    [J]. LUNG, 2020, 198 (06) : 947 - 955
  • [24] Protective effect of dexpanthenol on bleomycin-induced pulmonary fibrosis in rats
    Ermis, Hilal
    Parlakpinar, Hakan
    Gulbas, Gazi
    Vardi, Nigar
    Polat, Alaadin
    Cetin, Asli
    Kilic, Talat
    Aytemur, Zeynep Ayfer
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2013, 386 (12) : 1103 - 1110
  • [25] Tanshinone IIA attenuates bleomycin-induced pulmonary fibrosis in rats
    He, Huanyu
    Tang, Haiying
    Gao, Lili
    Wu, Yun
    Feng, Zhiqiang
    Lin, Hongli
    Wu, Taihua
    [J]. MOLECULAR MEDICINE REPORTS, 2015, 11 (06) : 4190 - 4196
  • [26] Therapeutic effects of α-lipoic acid on bleomycin-induced pulmonary fibrosis in rats
    Liu, Rui
    Ahmed, Kazi Mokim
    Nantajit, Danupon
    Rosenthal, Frank S.
    Hai, Chun-Xun
    Li, Jian Jian
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2007, 19 (06) : 865 - 873
  • [27] Plumbagin attenuates Bleomycin-induced lung fibrosis in mice
    Mehdizadeh, Saber
    Taherian, Marjan
    Bayati, Paria
    Mousavizadeh, Kazem
    Pashangzadeh, Salar
    Anisian, Ali
    Mojtabavi, Nazanin
    [J]. ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2022, 18 (01)
  • [28] NIACIN ATTENUATES BLEOMYCIN-INDUCED LUNG FIBROSIS IN THE HAMSTER
    WANG, QJ
    GIRI, SN
    HYDE, DM
    NAKASHIMA, JM
    JAVADI, I
    [J]. JOURNAL OF BIOCHEMICAL TOXICOLOGY, 1990, 5 (01): : 13 - 22
  • [29] Losartan attenuates bleomycin-induced pulmonary fibrosis in rats
    Yao, HW
    Zhu, JP
    Zhao, MH
    Lu, Y
    [J]. RESPIRATION, 2006, 73 (02) : 236 - 242
  • [30] ASTRAGALOSIDE ALLEVIATES BLEOMYCIN-INDUCED PULMONARY FIBROSIS IN RATS
    Yu, Wei-Na
    Sun, Li-Feng
    Yang, Hua
    [J]. ACTA MEDICA MEDITERRANEA, 2017, 33 (06): : 1151 - 1156